WHWK (Whitehawk Therapeutics) Short Interest


WHWK Whitehawk Therapeutics Inc WHWK
38 GF Score
Price $4.15
GF Value $0.27
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Whitehawk Therapeutics Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

WHWK vs VYGR, CRBU, OBIO: Short Interest Comparison

For the Biotechnology subindustry, Whitehawk Therapeutics's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Whitehawk Therapeutics Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Whitehawk Therapeutics's Short Interest distribution charts can be found below:

* The bar in red indicates where Whitehawk Therapeutics's Short Interest falls into.


WHWK
38GF Score
Whitehawk Therapeutics Inc WHWK
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Whitehawk Therapeutics (WHWK) Overvalued in 2026?

Based on GuruFocus' analysis, Whitehawk Therapeutics stock appears to be overvalued. The current stock price of $4.15 is trading 1437% above its estimated GF Value™ of $0.27. GuruFocus considers Whitehawk Therapeutics to be Significantly Overvalued.

Key valuation signals for WHWK:

  • Short Interest:
  • GF Value™: $0.27 vs. price of $4.15 (1437% above fair value)
  • GF Score™: 38/100 with 7 warning signs

No single metric tells the full story. See the WHWK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Whitehawk Therapeutics Business Description

Other Exchanges 3350:Germany
Address 2 Headquarters Plaza East Building, 11th Floor, Morristown, New Jersey, NJ, USA, 07960
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
38GF Score

Get the complete analysis for WHWK

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.15
Price
$0.27
GF Value